BostonGene Announces Research Collaboration with Leading Dana-Farber Cancer Center
BostonGene Corporation (BostonGene), a biomedical software company, based upon developing therapeutic precision therapies for cancer patients, has confirmed its partnership with the Weinstock Laboratory, a translation testing center on new treatments for lymphoid-malignant diseases at Dana-Farber Cancer Institute, Inc. This partnership aims to establish predictors for PI3 kinase inhibition in retroactive...